Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    Alaunos Therapeutics, Inc. (TCRT) Insider Trading Activity

    Healthcare • Biotechnology • 1 employees

    Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. The company is also developing hunTR, a human neoantigen TCR discovery engine; and Sleeping Beauty Gene Transfer Platform, a non-viral genetic engineering technology. The company was founded in 2003 and is headquartered in Houston, Texas.

    Total Value

    -$6,021.82

    Total Shares

    -3,000

    Average Trade Value

    -$3,010.91

    Most Active Insider

    Vieser Jaime

    Total Activity: $6,022

    Largest Single Transaction

    $4,386

    by Vieser Jaime on Dec 31, 2024

    30-Day Activity

    0 Transactions

    Volume: 0 shares
    Value: $0

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    Dec 31, 2024 2,182 $4,386 26,712 (-8.2%) Sale
    Dec 31, 2024 818 $1,636 25,894 (-3.2%) Sale